Assessing the Most Promising Areas for Vaccine Development Over the Next 15 Years
This webinar is based on our 2008 Pharmacor report, Emerging Vaccines. The session, presented by Analyst Hemali Patel, Ph.D., will discuss Decision Resources' methodology in assessing the emerging vaccines market and the factors that are driving favorable risk/benefit ratios for vaccines in the pipeline. The webinar will be held at 10 a.m U.S. Eastern Time on January 21, 2009.
Click here to learn more about this webinar.
Click here to register for this session.
Assessing the Impact of Medicare Reimbursement Changes and Evolving Resistance on the Prevention and Treatment of Hospital-Acquired Infections
This webinar is based on our 2008 Physician & Payer Forum report, Hospital Anti-Infectives: Insights on the Impact of Medicare Reforms, Formulary Inclusion, and Uptake of Novel Antibiotics and Antifungals. Because this webinar features major report findings, it is ONLY available to purchasers of this report.
Biologics Penetration of Early Lines of Therapy in Psoriasis, Crohn’s Disease and Rheumatoid Arthritis: Implications for Existing and Emerging Brands
This webinar is based on three of our 2008 Treatment Algorithms reports, Treatment Algorithms in Psoriasis , Treatment Algorithms in Crohn’s Disease and Treatment Algorithms in Rheumatoid Arthritis . Because this webinar features major report findings, it is ONLY available to purchasers of ONE of these reports.
Click here to learn how you can purchase the report and access a recorded playback of this event.
This panel discussion addresses three key themes affecting pharma covered in 2008 by our Spectrum analysts. Click here to access a recorded playback of the event.
Nosocomial Pneumonia: Analysis of Prescribing Patterns and Drivers and Opportunities in Drug Development
This webinar is based on Arlington Medical Resources (AMR) and Decision Resources September 2008 Hospital Anti-Infectives Insight Series report, Nosocomial Pneumonia. Because this webinar features major report findings, it is ONLY available to purchasers of this report.
Disease-Modifying Therapies for Osteoarthritis: Opportunities and Obstacles in Drug Development
This webinar, based on our 2008 Pharmacor report entitled Osteoarthritis: Disease-Modifying Therapies, focuses on, among other topics, the commercial potential for disease-modifying therapies in the OA market over the next decade and the drug discovery challenges, regulatory hurdles, and constraints to the uptake of agents for OA that drug developers must overcome.
Click here to access a recorded playback of the event.
Biosimilars: Who Will Benefit the Most From Growing Physician Awareness?
This webinar, based on our 2008 industry report entitled Biosimilars 2007-2017: Shifting Payer and Physician Opinion Increases the Hurdles to Uptake, focuses on how physician awareness of biosimilars has changed over the last year; what factors have constrained physician uptake of early-to-market biosimilars; and how shifting physician opinion will impact the potential uptake of future biosimilars.
Click here to access a recorded playback of this event.
Physician and Payer Perceptions of Novel Antiretrovirals for the Treatment of HIV
This webinar is based on our 2008 Physician & Payer Forum report, Novel HIV Therapies: Physician and Payer Perspective on Recently Launched and Emerging Antiretrovirals. Because this webinar features major report findings, it is ONLY available to purchasers of this report.
PatientFinder: A Novel Approach to Local Market Sizing
This webinar, is an introduction to our newest product PatientFinder. PatientFinder is an online, user-driven, flexible data set that you can easily manipulate to reveal the true disease opportunity at a local market level. This is the FIRST and ONLY healthcare analytics tool that assesses local markets for expansion opportunity by determining the number of insured patients in each territory who have a particular disease but are untreated.
Click here to access a playback of this event.
Hepatitis B in China and India: Market Strategies for Success
This webinar, based on our Emerging Markets-China and India report series, will, among other topics, highlight how the healthcare environment in China and India impacts the hepatitis B market in each country and will focus on the issues surrounding diagnosis and treatment of the disease in these two emerging markets.
Disruptions in the Alzheimer's Disease Market: The Impact of Razadyne's Genericization and the Launch of Biologic Disease-Modifying Drugs
This webinar is based on our 2008 Physician & Payer Forum report, The Impact of Razadyne’s Genericization and the Launch of Biologic Disease-Modifying Drugs on the Alzheimer’s Disease Market: Clinician and Payer Receptivity to Novel Agents. Because this webinar features major report findings, it is ONLY available to purchasers of this Physician & Payer Forum report.
Are Orphan Diseases an Entry Point to Larger Markets?
This webinar is based on our Orphan Disease Series reports, which provide critical market information for diseases with smaller patient populations, including disease prevalence, profiles of marketed and emerging agents and insight into the prescribing choices of disease specialists. Click here to access a playback of this event.
Opportunities for Emerging Disease-Modifying Therapies in Multiple Sclerosis
This webinar, based on our Treatment Algorithms in Multiple Sclerosis report, focuses on disease-modifying biologic drugs that gain the greatest patient shares in the earliest lines of therapy and key factors driving therapy choice among physicians. Click here to access a playback of this event.
Pharmaview Industry Outlook: Predictions for the Next 7 Years
Based on Decision Resources NEW Pharmaview product, this webinar will share the insight you need to understand how the pharmaceutical industry will evolve in the next 7 years. Click here to access a playback of this event.
Changes in Physician Sentiment in the Wake of Avandia
Based on our recent Physician and Payer Forum report, Avandia One Year Later: A Physician and Payer Perspective, Decision Resources is offering an exclusive, in-depth webinar entitled Changes in Physician Sentiment in the Wake of Avandia. Because this report will feature major report findings, it is only available to purchasers of this report.
Click here to contact us about purchasing this report and attending the webinar.
Emerging Targeted Therapies in Immune Indications: How Will Immune Disease Markets Respond to the Entry of at Least 15 New Immunomodulators by 2017?
Chronic Pain: Small Companies Devise Big Plans to Target Key Populations This webinar, based on our Pharmacor report entitled Chronic Pain, focuses on a number of smaller companies that are investigating analgesics to treat chronic pain in eight key indications.
Opportunities and Unmet Need in Psoriasis
This webinar, based on our recent DecisionBase 2008 Seminar, is led by Dr. Stephen Feldman. DecisionBase 2008 product combines market forecasts with clinical and commercial endpoints to assess patient share projections in 35 indications. These outputs are driven by quantitative and qualitative primary research. Dr. Feldman will utilize DecisionBase to explore the Opportunities and Unmet Need in Psoriasis.
Are the Glory Days of the U.S. Pharmaceutical Market in the Past? Pricing and Reimbursement Challenges Will Increase in the Years Ahead
This webinar, based on our Spectrum report, Pharmaceutical Pricing and Reimbursement in the United States, 2008 focuses on the affect of changing patterns of health insurance on the pharmaceutical industry; the impact of Medicare Part D on the U.S. prescription drug market; and many other issues currently facing the pharmaceutical industry.
Gastric Cancer in China
This webinar, based on our 2007 Brands & Strategies Report Series, tests the conventional wisdom regarding physician opinions within the drug market against findings from our primary research with primary care physicians and specialists.
Click here to learn more about this presentation.
Physician and Payer Perspectives on the Expanding Role of Biologics in Crohn’s Disease and Ulcerative Colitis
This webinar, based on our Physician & Payer Forum report entitled The Emergence of New Biologic Treatment Options for Crohn's Disease and Ulcerative Colitis: Physician and Payer Attitudes , focuses on which patient segments are currently treated with biologic agents and how biologic agents will expand into new patient populations in the coming years. The session also includes a discussion on how therapies in clinical development will compete with Remicade and Humira for a share of the market. Because this webinar features major report findings, it is ONLY available to purchasers of this report.
Myth Busters: Physician Perceptions of Companies & Brands
Obstacles and Opportunities in Cognitive Dysfunction: A Look at Cognitive Impairment Associated with Schizophrenia
This webinar, based on our Pharmacor report Cognitive Dysfunction, provides an overview of key issues in cognitive dysfunction, with a specific focus on the market for cognitive impairment associated with schizophrenia.
Multiple Myeloma: A Niche Cancer With a Robust Market
This webinar, based on our Multiple Myeloma Pharmacor report, focuses on the strengths and weaknesses of current major players in the multiple myeloma market, including Celgene’s Thalomid and Revlimid and Millennium/Johnson & Johnson’s Velcade, and their place in the treatment paradigm. The session also includes a pipeline analysis of promising drug classes and future launches, and their impact on currently available therapies. Because this webinar features major report findings, it is ONLY available to purchasers of this report.
